A single-center study to determine dosing schedules and duration of efficacy in patients with severe asthma receiving biologic therapy
Latest Information Update: 25 Jul 2022
At a glance
- Drugs Benralizumab (Primary) ; Dupilumab (Primary) ; Mepolizumab (Primary) ; Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 25 Jul 2022 New trial record